NEW MJ NEWS

TerrAscend Executive Chairman to Give Keynote at Benzinga Cannabis Capital Conference

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that its executive management team will participate in the Benzinga Cannabis Capital Conference being held April 11-12, 2023 at the Fontainebleau Miami Beach, Florida.

Jason Wild, TerrAscend’s Executive Chairman, will participate in a keynote presentation moderated by Tim Seymour of Seymour Asset Management on Tuesday, April 11, 2023, at 9:30 AM ET. Management will also host one-on-one meetings throughout the conference. For more information, please click here.

About TerrAscend

TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California and licensed production in Canada. TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Legend, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information visit www.terrascend.com.

SOURCE TerrAscend

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2023/10/c1579.html


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

TILT Holdings Inc. (TLLTF) Sets Third Quarter 2022 Conference Call for November 14 at 5:00 p.m. ET

TILT Sets Third Quarter 2022 Conference Call for November 14 at 5:00…

$NRTI Meets with Scientific/Medical Board To Plan for New CBD-Based Supplement Line

Inergetics’ Scientific/Medical Advisory Board Meets to Discuss Launch Preparations for its New…

Cronos Group Inc. (CRON) Files Form 12b-25

Cronos Group Files Form 12b-25 Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON)…

Nabis Holdings (NABIF) (CSE:NAB) Announces Closing of $35 Million Private Placement of Debenture Units

VANCOUVER, British Columbia, March 26, 2019 (GLOBE NEWSWIRE) — Nabis Holdings (CSE:NAB;…